Compounds > bromocriptine
Page last updated: 2024-08-23

bromocriptine and Cancer of Pancreas

bromocriptine has been researched along with Cancer of Pancreas in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, CX; Qu, HQ; Tian, WJ; Wang, BP; Zhang, J; Zhu, M1
Burshell, AL; Pathak, RD; Tran, TH1
Ezrin, C; Ezzat, S; Melmed, S; Yamashita, S1
De Herder, WW; Hofland, LJ; Kros, MJ; Lamberts, SW; Uitterlinden, P; Van Koetsveld, PM; Van Uffelen, C; Visser-Wisselaar, HA; Waaijers, M; Zuyderwijk, J1
de Herder, WW; Hofland, LJ; Lamberts, SW; Uitterlinden, P; van Koetsveld, PM; Waaijers, M; Zuijderwijk, J1
Child, DF; Ganguli, PC; Laing, I1

Other Studies

6 other study(ies) available for bromocriptine and Cancer of Pancreas

ArticleYear
Nonfunctional pancreatic endocrine tumor in the peripancreatic region in a Chinese patient with multiple endocrine neoplasia type 1.
    The Journal of international medical research, 2018, Volume: 46, Issue:2

    Topics: Adult; Amino Acid Substitution; Bone and Bones; Bromocriptine; Female; Gene Expression; Hormone Antagonists; Humans; Multiple Endocrine Neoplasia Type 1; Mutation, Missense; Pain; Pancreatic Neoplasms; Prolactinoma; Proto-Oncogene Proteins; Tomography, X-Ray Computed

2018
A case of dopamine agonists inhibiting pancreatic polypeptide secretion from an islet cell tumor.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:2

    Topics: Adenoma, Islet Cell; Bromocriptine; Chromogranin A; Chromogranins; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Liver Neoplasms; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Pancreatic Polypeptide; Prolactinoma

2004
Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumor.
    Cancer, 1993, Jan-01, Volume: 71, Issue:1

    Topics: Acromegaly; Bromocriptine; Gene Expression Regulation, Neoplastic; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Prolactin; Recurrence; Thyrotropin; Thyrotropin-Releasing Hormone

1993
Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:9

    Topics: Adenoma; Adenoma, Islet Cell; Aminoquinolines; Bromocriptine; Dopamine Agonists; Endocrine Gland Neoplasms; Hormone Antagonists; Hormones; Humans; Insulinoma; Pancreatic Neoplasms; Pituitary Neoplasms; Prolactinoma; Receptors, Somatostatin; Somatostatin; Tumor Cells, Cultured

1997
Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:9

    Topics: Adenoma; Bromocriptine; Dopamine Agonists; Gastrinoma; Gastrins; Human Growth Hormone; Humans; Insulin; Insulin Secretion; Insulinoma; Interferon alpha-2; Interferon-alpha; Octreotide; Pancreatic Neoplasms; Pituitary Neoplasms; Prolactin; Prolactinoma; Recombinant Proteins; Somatostatin; Tumor Cells, Cultured

1999
Failure of oral bromocriptine to affect hypergastrinemia in two patients with the Zollinger-Ellison syndrome.
    Journal of endocrinological investigation, 1978, Volume: 1, Issue:4

    Topics: Adenoma; Adenoma, Islet Cell; Adult; Bromocriptine; Gastrins; Growth Hormone; Humans; Male; Middle Aged; Pancreatic Neoplasms; Peptic Ulcer; Zollinger-Ellison Syndrome

1978